|
f4b82ce7-326d-4c99-ac26-a13a3b09f1e9
|
34c7193c-d96f-448e-a617-43d60071f00f
|
letters-2025_12_11_114708_693b11ac7244a_8981.pdf
|
{"name": "letters-2025_12_11_114708_69 {"name": "letters-2025_12_11_114708_693b11ac7244a_8981.pdf", "content_type": "application/octet-stream", "size": 38800, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-f4b82ce7-326d-4c99-ac26-a13a3b09f1e9"}...
|
1772237237
|
9b058184875797e9610aee2bf5865da00667f289bd2c91539b 9b058184875797e9610aee2bf5865da00667f289bd2c91539b48bf29f8aa43f4...
|
{"status": "completed", "conte {"status": "completed", "content": "Advanced Cardiology Consultants & Diagnostic Inc\n#250 8500 Blackfoot Trail SE\nCalgary, AB, T2J7E1\nTel: 403-879-7911 | Fax 403-879-7899\nNUCLEAR MYOCARDIAL PERFUSION IMAGING EXERCISE STRESS STUDY\nDecember 11, 2025 Chart No: A43819\nRef. Dr.: Dr. Ali Debek Family Dr.:\nRE: Div Kash Supervising MD:Dr. Daniel Anselm\nPHN: 666777888 Technologist:\nDOB: 12 December, 2025 Gender: Female\nClinical History:Z\n- Chest Pain\nECG Information Resting ECG: zx\n- Horizontal ST changes in the Inferolateral Lead\nExercise Stress Test Information\nInterpretation by: Dr. Daniel Anselm Stress Interpretation ECG:\nProtocol: Symptoms During Test: METS achieved:\nPeak HR: zxzxz Peak HR % Achieved: Exercise Duration:\nReason of Termination: zx\nProtocol completed\nStage Heart Rate (bpm) Blood Pressure\nRest\n1 zx\n2\n3\n4\n5\nRecovery\nMPI Technique:\nMbq of 99m Tc-Tetrofosmin was administered intravenously at rest and\nMbq of 99m Tc-Tetrofosmin was administered intravenously at peak stress following Exercise Myocardial Perfusion.\nMultiple gated tomographic emission images were obtained post stress and at rest. These images were reconstructing\ninto short axis, vertical long axis and horizontal long axis planes.\nImage quality:\nFindings:\nThere is normal myocardial perfusion. No fixed or reversible perfusion abnormalities are identified.\nThe left ventricle is normal in size. All left ventricular segments thicken and contract normally. The left ventricular ejection\nfraction is >50% post stress and >50% at rest. There is no visual evidence of TID.\nImpression:\nNormal myocardial perfusion and left ventricular systolic function.\nMPI Interpreting Physician: Ramu Report Date: December 11, 2025\nInformation contained in this communication may be confidential and is intended only for the use of the recipient(s). If the reader of this\nmessage is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication or any\nof its contents is strictly prohibited. If you received this communication in error please return it to the sender and contact Advanced\nCardiology on 403-8797899 .\nName: Div Kash | PHN: 666777888 | DOB: 12 Dec, 2025 Page 1 Of 1"}...
|
1772237237
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f4b82ce7-326d-4c99-ac26-a13a3b09f1e9_letters-2025_12_11_114708_693b11ac7244a_8981.pdf...
|
null
|
Edit
Delete
|
|
f60993c8-f0b8-46c5-ab53-b27a2da49cd0
|
43b8b4ba-6a86-4e7d-8af9-bdff9b8db2e6
|
AI Development for Genomic Analysis.pptx
|
{"name": "AI Development for Genomic A {"name": "AI Development for Genomic Analysis.pptx", "content_type": "application/vnd.openxmlformats-officedocument.presentationml.presentation", "size": 4407937, "data": {}, "collection_name": "file-f60993c8-f0b8-46c5-ab53-b27a2da49cd0"}...
|
1774048436
|
e02c7165ff9045b254b1b53956ad93fbcd2731c51251440b20 e02c7165ff9045b254b1b53956ad93fbcd2731c51251440b2033bd858a421c24...
|
{"status": "completed", "conte {"status": "completed", "content": "AI Development for Genomic Analysis\n\n2022-07-05\n\n\n\nNGS Genetic Test Laboratory Workflow\n\n\n\nSequencing\n\nBioinformatics (10, 20, 30 etc.)\n\nLibrary Preparation\n\nLibrary to flow cell\n\nGenerate FASTQ\n\nSample collection\n\nMap to ref genome (G37/38)\n\nClustering\n\nNA Extraction (DNA, RNA)\n\nAlignment/Deduplication/Recalibration\n\nTagmentation/Ligation & Cleanup \n\n(Bead based NA fragmentation)\n\nPaired-end Seq \n\n(by synthesis)\n\nVariant calling\n\nFiltering\n\nCNV caller\n\nStructural variants (insertions, deletions, inversions, missense)\n\nDenova Assembly\n\n\n\nBioinformatics; General workflow\n\nWe not only want to develop the tertiary analysis software, but also the secondary.\n\nMany steps involved and we want to make sure that the final product is robust and calls\u00a0accurately.\n\nMy experience is based on script curation and application, not yet optimization.\n\n\n\nNGS - Genomic Variant analysis flowchart (WGS/WES)\n\n\n\nScript Curation\n\nA typical workflow is to:\n\nSequence the whole genome or exome\n\nPerform quality control and trim\u00a0\n\nAlign to a high-quality reference\u00a0\n\nIdentify SNVs or short INDELs,\u00a0\n\nAnnotate the variants.\n\nTo understand the process better, please refer to: https://www.frontiersin.org/articles/10.3389/fgene.2020.544162/full\u00a0\n\n\n\nPrimary analysis\n\nSecondary analysis\n\nTertiary analysis\n\n\n\n\n\nInput Data\n\nVCF file would be uploaded to be:\n\nFiltered\n\nAnnotated\n\nInterpreted \n\n\n\nWhat the columns mean:\n\n\n\n\n\nThe 'Format' column\n\nGT : The genotype of this sample at this site. For a diploid organism, the GT field indicates the two alleles carried by the sample, encoded by a 0 for the REF allele, 1 for the first ALT allele, 2 for the second ALT allele, etc. When there's a single ALT allele (by far the more common case), GT will be either:\n\n0/0 - the sample is homozygous reference\n\n0/1 - the sample is heterozygous, carrying 1 copy of each of the REF and ALT alleles\n\n1/1 - the sample is homozygous alternate\n\nFor non-diploids, the same pattern applies; in the haploid case there will be just a single value in GT; for polyploids there will be more, e.g. 4 values for a tetraploid organism.\n\nAD and DP : Allele depth and depth of coverage. These are complementary fields that represent two important ways of thinking about the depth of the data for this sample at this site. AD is the unfiltered allele depth, i.e. the number of reads that support each of the reported alleles. All reads at the position (including reads that did not pass the variant caller's filters) are included in this number, except reads that were considered uninformative. Reads are considered uninformative when they do not provide enough statistical evidence to support one allele over another. DP is the filtered depth, at the sample level. This gives you the number of filtered reads that support each of the reported alleles. You can check the variant caller's documentation to see which filters are applied by default. Only reads that passed the variant caller's filters are included in this number. However, unlike the AD calculation, uninformative reads are included in DP. See the Tool Documentation for more details on AD (DepthPerAlleleBySample) and DP (Coverage) for more details.\n\nPL : \"Normalized\" Phred-scaled likelihoods of the possible genotypes. For the typical case of a monomorphic site (where there is only one ALT allele) in a diploid organism, the PL field will contain three numbers, corresponding to the three possible genotypes (0/0, 0/1, and 1/1). The PL values are \"normalized\" so that the PL of the most likely genotype (assigned in the GT field) is 0 in the Phred scale. We use \"normalized\" in quotes because these are not probabilities. We set the most likely genotype PL to 0 for easy reading purpose.The other values are scaled relative to this most likely genotype. Keep in mind, if you're not familiar with the statistical lingo, that when we say PL is the \"Phred-scaled likelihood of the genotype\", we mean it is \"How much less likely that genotype is compared to the best one\". Have a look at this article for an example of how PL is calculated.\n\nGQ : Quality of the assigned genotype. The Genotype Quality represents the Phred-scaled confidence that the genotype assignment (GT) is correct, derived from the genotype PLs. Specifically, the GQ is the difference between the PL of the second most likely genotype, and the PL of the most likely genotype. As noted above, the values of the PLs are normalized so that the most likely PL is always 0, so the GQ ends up being equal to the second smallest PL, unless that PL is greater than 99. In GATK, the value of GQ is capped at 99 because larger values are not more informative, but they take more space in the file. So if the second most likely PL is greater than 99, we still assign a GQ of 99. Basically the GQ gives you the difference between the likelihoods of the two most likely genotypes. If it is low, you can tell there is not much confidence in the genotype, i.e. there was not enough evidence to confidently choose one genotype over another. See the FAQ article on the Phred scale to get a sense of what would be considered low. Not to be confused with the site-level annotation QUAL; see this FAQ article for an explanation of the differences in what they mean and how they should be used.\n\n\n\nWhat ALT can look like based on type of change:\n\n\n\nFiltering down the variants:\n\n\n\nOutput\n\nA report that has been generated from the json file \u2013 outlining the results from the filtering process during variant analysis. \n\nThe results are associated with evidence from literature found in the databases sent in list format previously via email. "}...
|
1774048436
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f60993c8-f0b8-46c5-ab53-b27a2da49cd0_AI Development for Genomic Analysis.pptx...
|
null
|
Edit
Delete
|
|
f6210465-cac2-4420-8b37-096055b7943e
|
34c7193c-d96f-448e-a617-43d60071f00f
|
dictations-2025_11_10_140138.pdf
|
{"name": "dictations-2025_11_10_140138 {"name": "dictations-2025_11_10_140138.pdf", "content_type": "application/octet-stream", "size": 52172, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-f6210465-cac2-4420-8b37-096055b7943e"}...
|
1772237354
|
b8132329c8817261ec45ba5a019b5df630ef3cbd8cf1f54234 b8132329c8817261ec45ba5a019b5df630ef3cbd8cf1f54234bf8bd101bc3045...
|
{"status": "completed", "conte {"status": "completed", "content": "52 Castelfall way NEasdasdasd\ncalgary, asdsadsad, t3j1m7\nTel:1234567876 Fax:1234345676\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n#250 8500 Blackfoot Trail SE Calgary, AB T2J 7E1\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Tel 403-879-7911 Fax 403-879-7899\nFaxTo:\u00a0\u00a0Aamer, Nazish From:\u00a0Advanced Rheumatology\nFax:\u00a0\u00a0 Pages: 1\nPhone:\u00a0\u00a0- Date:\u00a0\u00a010 November 2025\nRe:\u00a0\u00a0Div Kash CC:\nThank you for your referral.\n\u00a0\nPlease be advised that Dr. Dhalla / Advanced Rheumatology can only provide evaluation for pediatric patients at\nthis time. As the referred patient is over the age of 18 they cannot be seen and the file will be closed. We will\ndirect this referral to rheumatology central triage (see above) but would recommend you also send a referral in\nto ensure it is processed and that you can be sent a status update, and/or consider referral to any of the private\nrheumatology practices in the city.\n\u00a0\nAt this time we will close the file. If there is anything further we can do to assist you, please contact us at 403-\n879-7911 or Fax 403-879-7899.\n\u00a0\nThank you,\nDr. Dhalla\nPatient Care Coodinator\n\u00a0\n\u00a0\nInformation contained in this communication may be confidential and is intended only for the use of the\nrecipient(s). If the reader of this message is not the intended recipient, you are hereby notified that any\ndissemination, distribution, or copying of this communication or any of its contents is strictly prohibited. If you\nreceived this communication in error, Please return it to the sender and contact Advanced Cardiology 403-879-\n7911.\nPage 1 of 1\nName: Div Kash | PHN: 666777888 | DOB: 12 Dec, 2025"}...
|
1772237354
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f6210465-cac2-4420-8b37-096055b7943e_dictations-2025_11_10_140138.pdf...
|
null
|
Edit
Delete
|
|
f7155f6e-8419-4c20-a698-53f9368df653
|
34c7193c-d96f-448e-a617-43d60071f00f
|
dictations-2025_12_16_031948.pdf
|
{"name": "dictations-2025_12_16_031948 {"name": "dictations-2025_12_16_031948.pdf", "content_type": "application/octet-stream", "size": 81950, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-f7155f6e-8419-4c20-a698-53f9368df653"}...
|
1772237317
|
d1bd3115c1dfdb6851a6ac8ef20c545629d85307ba8c38f0a4 d1bd3115c1dfdb6851a6ac8ef20c545629d85307ba8c38f0a441955f574df970...
|
{"status": "completed", "conte {"status": "completed", "content": "52 Castelfall way NEasdasdasd\ncalgary, asdsadsad, t3j1m7\nTel:1234567876 Fax:1234345676\nChart Number : A43819\nAaron, Stephen\nFax: 5345435435345345435\n\u00a0\nRE: Div Kash\nPHN: 666777888\nDOB: 1998-12-12\n\u00a0\nDear Aaron, Stephen,\n\u00a0\n\u00a0\nLorem Ipsum\u00a0is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the\nindustry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and\nscrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into\nelectronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of\nLetraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus\nPageMaker including versions of Lorem Ipsum.\nWhy do we use it?\nIt is a long established fact that a reader will be distracted by the readable content of a page when looking at its\nlayout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to\nusing 'Content here, content here', making it look like readable English. Many desktop publishing packages and\nweb page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover\nmany web sites still in their infancy. Various versions have evolved over the years, sometimes by accident,\nsometimes on purpose (injected humour and the like).\n\u00a0\nWhere does it come from?\nContrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin\nliterature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney\nCollege in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage,\nand going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum\ncomes from sections 1.10.32 and 1.10.33 of \"de Finibus Bonorum et Malorum\" (The Extremes of Good and Evil)\nby Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance.\nThe first line of Lorem Ipsum, \"Lorem ipsum dolor sit amet..\", comes from a line in section 1.10.32.\nThe standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections\n1.10.32 and 1.10.33 from \"de Finibus Bonorum et Malorum\" by Cicero are also reproduced in their exact original\nform, accompanied by English versions from the 1914 translation by H. Rackham.\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0Name: Div Kash | PHN: 666777888 | DOB: 12 Dec, 1998 Page Page 1 of 2 Yours Sincerely,\n\u00a0\n\u00a0\nDictation file: Super Admin\n\u00a0\nDICTATED BUT NOT READ TO AVOID DELAY\n\u00a0\nInformation contained in this communication may be confidential and is intended only for the use of the recipient(s). If the\nreader of this message is not the intended recipient, you are hereby notified that any dissemination, distribution, or\ncopying of this communication or any of its contents is strictly prohibited. If you received this communication in error,\nPlease return it to the sender and contact Advanced Cardiology 403-235-4109.\ntest\nPage 2 of 2Name: Div Kash | PHN: 666777888 | DOB: 12 Dec, 1998 Page"}...
|
1772237317
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f7155f6e-8419-4c20-a698-53f9368df653_dictations-2025_12_16_031948.pdf...
|
null
|
Edit
Delete
|
|
f7cf6f59-e6fd-4728-9b93-dcf57416fc5d
|
34c7193c-d96f-448e-a617-43d60071f00f
|
letters-AC2251391.pdf
|
{"name": "letters-AC2251391.pdf", {"name": "letters-AC2251391.pdf", "content_type": "application/octet-stream", "size": 78295, "data": {"patient_id": "3e448bf0-0f45-11f0-8be5-73d44ea410c5"}, "collection_name": "file-f7cf6f59-e6fd-4728-9b93-dcf57416fc5d"}...
|
1772236887
|
233ce323d7448a69d272dbbb1a154ec75dda0a5153a080df57 233ce323d7448a69d272dbbb1a154ec75dda0a5153a080df57d87e0d64c80e3a...
|
{"status": "completed", "conte {"status": "completed", "content": "Page 1 of 2 Exam Date (M/D/Y): 4/4/2025\n201, 3151 27 st NE Calgary, Alberta T1Y 0B4T: 403.235.4109F: 403.235.4147www.advancedcardiology.ca\n Meadow MilesSuite 250 \u2013 8500 Blackfoot Trail SECalgary AB, T2J 7E1Tel 403-879-7911Fax 403-879-7899 Transthoracic EchocardiographyMuhammed SyedDOB(M/D/Y): 08/15/1991 (33 years)PHN#: 150702091Sex: male Height: 174 cmWeight: 75 kgBSA: 1.90 m2BP: 122/80Report finalized\nDate of Study: 4/4/2025Report Date: 4/4/2025Sonographer: Mia Interpreted by: Anmol Kapoor, MD FRCPCReferred by: Ravi VarshneyLoca=on: ACCD Meadow MilesMeasureM mode LVRWT 0.41 [0.24-0.42]2D mode IVSd 0.9cm LVIDd 4.6cm [4.2-5.8] LVIDs 2.7cm [2.5-4.0] LV FS 41%\n LVPWd 0.9cm LVd Mass (ASE) 142g LVd Mass Index (ASE) 75g/m\u00b2 LA Diam 3.4cm [3.0-4.0]\n LAAs (A4C) 16.3cm\u00b2 LAESVI (A-L) 26ml/m\u00b2 Ao Root Diam 2.9cm [2.3-2.9] Ao Asc Diam\n 2.6cm [2.6-3.4]Doppler MV E Velocity 0.9m/s MV A Velocity 0.9m/s MV E / A 1.0 [0.7-2.3] MV Dec. Time 172ms [138-194] MV Dec. Slope 5.2m/s\u00b2TDI MV E' Sept\n 9.1cm/s [10.1-20.9] MV E / E' Sept 9.9 MV E' Lat 17.7cm/s [14.0-25.6] MV E / E' Lat 5.1 MV E' Avg 13cm/s MV E / E' Avg 6.7Indica=onHeart Murmur. ? RheumaAc Heart DiseaseStudy Type/Study QualityA transthoracic study was performed including 2D, M-mode, spectral, color-flow and TissueDoppler imaging. View: The image quality was adequateECG/RhythmSinus rhythm. LeA VentricleThe leF ventricular cavity size is normal. LV wall thickness is normal. Global systolic funcAon: Systolic funcAon is normal with an EF > 60% . Page 2 of 2 Exam Date (M/D/Y): 4/4/2025\nDiastolicFunc=onThe diastolic filling paLern is normal for the age of the paAent. Right VentricleNormal right ventricular size and systolic funcAon. LeA AtriumThe leF atrial volume is normal.Right AtriumThe right atrial size is normal. Aor=c ValveThe aorAc valve is trileaflet and structurally normal. No evidence of valvular aorAc stenosis.There is no aorAc insufficiency by color or spectral Doppler. Mitral ValveThe mitral valve is structurally normal. Mild mitral annular calcificaAon present. No evidenceof mitral stenosis is seen. There is trace mitral regurgitaAon present. Tricuspid ValveThe TV was structurally normal. There was no tricuspid stenosis. There is physiologicaltricuspid regurgitaAon. The RVSP could not be esAmated. Pulmonic ValvePulmonic valve appears structurally normal. No evidence of pulmonic stenosis. Trace pulmonic regurgitaAon. PericardiumThere is no pericardial effusion. Shunts Patent foramen ovale: There was no Patent Foramen Ovale detected by colour Doppler. IVC/Hepa=cVeins Normal inferior vena cava. Normal inspiratory response. Aorta The aorAc root, ascending aorta , aorAc arch and descending aorta are all normal in size. PulmonaryArteryNormal pulmonary artery. PulmonaryVeins The flow paLerns appear normal.IMPRESSION:1. Systolic func=on is normal with an EF > 60% .2. No hemodynamically significant valvular abnormalityAnmol Kapoor, MD FRCPC Mia Cardiologist Sonographer"}...
|
1772236887
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f7cf6f59-e6fd-4728-9b93-dcf57416fc5d_letters-AC2251391.pdf...
|
null
|
Edit
Delete
|
|
f856f332-7e5e-41d1-97fb-0c8f747057f5
|
34c7193c-d96f-448e-a617-43d60071f00f
|
dictations-2025_12_16_030312.pdf
|
{"name": "dictations-2025_12_16_030312 {"name": "dictations-2025_12_16_030312.pdf", "content_type": "application/octet-stream", "size": 84637, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-f856f332-7e5e-41d1-97fb-0c8f747057f5"}...
|
1772237322
|
8925b146ef8cfa5623f14ef0883787d2e0ff415a8a2268fe46 8925b146ef8cfa5623f14ef0883787d2e0ff415a8a2268fe46dff6ec869cc077...
|
{"status": "completed", "conte {"status": "completed", "content": "52 Castelfall way NEasdasdasd\ncalgary, asdsadsad, t3j1m7\nTel:1234567876 Fax:1234345676\nChart Number : A43819\nAaron, Stephen\nFax: 5345435435345345435\n\u00a0\nRE: Div Kash\nPHN: 666777888\nDOB: 1998-12-12\n\u00a0\nDear Aaron, Stephen,\n\u00a0\n\u00a0\n\u00a0\nLorem Ipsum\u00a0is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the\nindustry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and\nscrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into\nelectronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of\nLetraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus\nPageMaker including versions of Lorem Ipsum.\nWhy do we use it?\nIt is a long established fact that a reader will be distracted by the readable content of a page when looking at its\nlayout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to\nusing 'Content here, content here', making it look like readable English. Many desktop publishing packages and\nweb page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover\nmany web sites still in their infancy. Various versions have evolved over the years, sometimes by accident,\nsometimes on purpose (injected humour and the like).\n\u00a0\nWhere does it come from?\nContrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin\nliterature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney\nCollege in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage,\nand going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum\ncomes from sections 1.10.32 and 1.10.33 of \"de Finibus Bonorum et Malorum\" (The Extremes of Good and Evil)\nby Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance.\nThe first line of Lorem Ipsum, \"Lorem ipsum dolor sit amet..\", comes from a line in section 1.10.32.\nThe standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections\n1.10.32 and 1.10.33 from \"de Finibus Bonorum et Malorum\" by Cicero are also reproduced in their exact original\nform, accompanied by English versions from the 1914 translation by H. Rackham.\n\u00a0\nLorem Ipsum\u00a0is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the\nindustry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and\nscrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into\nName: Div Kash | PHN: 666777888 | DOB: 12 Dec, 1998\nPage 1 of 3 electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of\nLetraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus\nPageMaker including versions of Lorem Ipsum.\nWhy do we use it?\nIt is a long established fact that a reader will be distracted by the readable content of a page when looking at its\nlayout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to\nusing 'Content here, content here', making it look like readable English. Many desktop publishing packages and\nweb page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover\nmany web sites still in their infancy. Various versions have evolved over the years, sometimes by accident,\nsometimes on purpose (injected humour and the like).\n\u00a0\nWhere does it come from?\nContrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin\nliterature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney\nCollege in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage,\nand going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum\ncomes from sections 1.10.32 and 1.10.33 of \"de Finibus Bonorum et Malorum\" (The Extremes of Good and Evil)\nby Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance.\nThe first line of Lorem Ipsum, \"Lorem ipsum dolor sit amet..\", comes from a line in section 1.10.32.\nThe standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections\n1.10.32 and 1.10.33 from \"de Finibus Bonorum et Malorum\" by Cicero are also reproduced in their exact original\nform, accompanied by English versions from the 1914 translation by H. Rackham.\n\u00a0\nLorem Ipsum\u00a0is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the\nindustry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and\nscrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into\nelectronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of\nLetraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus\nPageMaker including versions of Lorem Ipsum.\nWhy do we use it?\nIt is a long established fact that a reader will be distracted by the readable content of a page when looking at its\nlayout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to\nusing 'Content here, content here', making it look like readable English. Many desktop publishing packages and\nweb page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover\nmany web sites still in their infancy. Various versions have evolved over the years, sometimes by accident,\nsometimes on purpose (injected humour and the like).\n\u00a0\nWhere does it come from?\nContrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin\nliterature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney\nCollege in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage,\nand going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum\ncomes from sections 1.10.32 and 1.10.33 of \"de Finibus Bonorum et Malorum\" (The Extremes of Good and Evil)\nby Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance.\nName: Div Kash | PHN: 666777888 | DOB: 12 Dec, 1998\nPage 2 of 3 The first line of Lorem Ipsum, \"Lorem ipsum dolor sit amet..\", comes from a line in section 1.10.32.\nThe standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections\n1.10.32 and 1.10.33 from \"de Finibus Bonorum et Malorum\" by Cicero are also reproduced in their exact original\nform, accompanied by English versions from the 1914 translation by H. Rackham.\n\u00a0\nYours Sincerely,\n\u00a0\n\u00a0\nDictation file: Super Admin\n\u00a0\nDICTATED BUT NOT READ TO AVOID DELAY\n\u00a0\nInformation contained in this communication may be confidential and is intended only for the use of the recipient(s). If the\nreader of this message is not the intended recipient, you are hereby notified that any dissemination, distribution, or\ncopying of this communication or any of its contents is strictly prohibited. If you received this communication in error,\nPlease return it to the sender and contact Advanced Cardiology 403-235-4109.\ntest\nPage 3 of 3\nName: Div Kash | PHN: 666777888 | DOB: 12 Dec, 1998"}...
|
1772237322
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f856f332-7e5e-41d1-97fb-0c8f747057f5_dictations-2025_12_16_030312.pdf...
|
null
|
Edit
Delete
|
|
f86cb5c0-0ef8-4064-863f-0b608fde0ee8
|
34c7193c-d96f-448e-a617-43d60071f00f
|
dictations-1766072646598.pdf
|
{"name": "dictations-1766072646598.pdf {"name": "dictations-1766072646598.pdf", "content_type": "application/octet-stream", "size": 48009, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-f86cb5c0-0ef8-4064-863f-0b608fde0ee8"}...
|
1772237296
|
d127e2b9b5a40fec0d9cfa667e30fc88f20cf1a0a7a04d249a d127e2b9b5a40fec0d9cfa667e30fc88f20cf1a0a7a04d249a2096d70557539f...
|
{"status": "completed", "conte {"status": "completed", "content": "Logo\nAdvanced Cardiology Consultants & Diagnostic Inc\n#250 8500 Blackfoot Trail SE\nCalgary, AB, T2J7E1\nTel: 403-879-7911 | Fax 403-879-7899\nDictation Letter\nDate: 12/18/2025 Chart No: A43819\nPatient: Div Kash\nPhysician:\nSubject: Dictation Letter - Super Admin\nInformation contained in this communication may be confidential and is intended only for the use of the recipient(s)..."}...
|
1772237296
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f86cb5c0-0ef8-4064-863f-0b608fde0ee8_dictations-1766072646598.pdf...
|
null
|
Edit
Delete
|
|
f96a01e3-a7ff-4d32-be53-213f04b80a75
|
34c7193c-d96f-448e-a617-43d60071f00f
|
labs-a9121b4c-ac52-49fb-a95d-e010c5d7b07b.pdf
|
{"name": "labs-a9121b4c-ac52-49fb-a95d {"name": "labs-a9121b4c-ac52-49fb-a95d-e010c5d7b07b.pdf", "content_type": "application/octet-stream", "size": 641039, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-f96a01e3-a7ff-4d32-be53-213f04b80a75"}...
|
1772237229
|
8c85e3e76c000cf57dbdb7e8e75e1252d1b7ad38c744e3e150 8c85e3e76c000cf57dbdb7e8e75e1252d1b7ad38c744e3e150e27043e83bbfc9...
|
{"status": "completed", "conte {"status": "completed", "content": "ABATACEPT for Polyarticular Juvenile \nIdiopathic Arthritis \nSPECIAL AUTHORIZATION REQUEST FORM \nPlease complete all required sections to allow your request to be processed. Patients may or may not meet eligibility requirements as established \nby Alberta Government sponsored drug programs. \nPATIENT INFORMATION COVERAGE TYPE\nPATIENT LAST NAME FIRST NAME INITIAL\n Alberta Blue Cross \n Alberta Human Services \n Other\nDATE OF BIRTH: YYYY/MM/DD ALBERTA PERSONAL HEALTH NUMBER\nSTREET ADDRESS CITY PROV POSTAL CODE ID /CLIENT/COVERAGE N UMBER \nPRESCRIBER INFORMATION \nPRESCRIBER LAST NAME FIRST NAME INITIAL PRESCRIBER PROFESSIONAL ASSOCIATION REGISTRATION \n CPSA \n CARNA \n ACP \n ACO \n ADA+C \n Other \nREGISTRATION NUMBER \nSTREET ADDRESS \nPHONE FAX \nCITY, PROVINCE \nPOSTAL CODE FAX NUMBER MUST BE PROVIDED WITH EACH REQUEST SUBMITTED \nPlease provide the following information for ALL requests \nDiagnosis \n Polyarticular Juvenile Idiopathic Arthritis \n Other ( please specify) ______________________ \nCurrent weight (kg) Dosage \nDosing frequency \nPlease provide reason if a switch from a different biologic agent to abatacept is requested \nNote: Patients will not be permitted to switch back to a previously trialed biologic agent if they were deemed unresponsive to ther apy \nCurrent ACR Pedi 30 FLARE score (provide for ALL requests) \nACR Pedi 30 RESPONSE score at 16 to 20 weeks after first dose \nof previous abatacept treatment (provide for RETREATMENT \nrequests) \nDate of assessment___________________________ \n1. R\nheumatologist global 4. No. of joints\na\nssessment (0-10) ___________ w\nith LROM ___________ \n2. P\natient global 5. CHA\nQ (0-3) ___________\nassessment (0-10) ___________\n3. No\n. of active joints* ___________ 6. ESR (mm/hr) ____ ______\n or CRP ______________\n*joints with swelling not due to deformity or joints with limitation of motion with pain,\ntenderness or both\nDate of assessment___________________________ \n1. R\nheumatologist global 4. No. of joints\na\nssessment (0-10) ___________\nwith LROM ___________ \n2. P\natient global 5. CHA\nQ (0-3) ___________\nassessment (0-10) ___________\n3. N\no. of active joints* ___________ 6. ESR (mm/hr) _____ _____\n or CRP ______________\n*joints with swelling not due to deformity or joints with limitation of motion with pain,\ntenderness or both\nPlease provide the following information for ALL NEW requests \nPrevious medications utilized: Dose, duration and response is required \n DMARD(s) (please specify agents) \n Adalimumab\n Etanercept \n Tocilizumab \n Other (please specify agent) \nAdditional information relating to request (e.g. reasons why any of the above therapies were not tried) \nPRESCRIBER'S SIGNATURE DATE Please forward this request to \nAlberta Blue Cross, Clinical Drug Services \n10009 108 Street NW, Edmonton, Alberta T5J 3C5 \nFAX: 780 498-8384 in Edmonton \u2022 1-877-828-4106 toll free all other areas \nONCE YOUR REQUEST HAS SUCCESSFULLY TRANSMITTED, PLEASE DO NOT MAIL OR RE-FAX YOUR REQUEST \nThe information on this form is being collected and pursuant to sections 20, 21 and 22 of the Health Information Act, and sec tions 33 and 34 of the Freedom of Information and \nProtection of Privacy Act, for the purposes of determining or verifying eligibility to participate in a program or receive a benefit, product or health service. If you have any questions \nregarding the collection or use of this information, please contact an Alberta Blue Cross privacy matters representative toll -free at 1-855-498-7302 or write to Privacy Matters, \nAlberta Blue Cross, 10009 108 Street, Edmonton AB T5J 3C5. \n \u00ae*The Blue Cross symbol and name are registered marks of the Canadian Association of Blue Cross Plans, an association of independent Blue Cross plans. Licensed to ABC \nBenefits Corporation for use in operating the Alberta Blue Cross Plan. \u00ae\u2020 Blue Shield is a registered trade- mark of the Blue Cross Blue Shield Association. \nABC 60010 (2016/10) \nKash abcdks\nDiv alien\n1998-12-11\n578788878\nMequanent\n52 Castlefall Way NE\nCaglary\nT3J1M7\ncalgary\nT1Y6L4\n1\n4036481926\nChoose Province\nTed"}...
|
1772237229
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/f96a01e3-a7ff-4d32-be53-213f04b80a75_labs-a9121b4c-ac52-49fb-a95d-e010c5d7b07b.pdf...
|
null
|
Edit
Delete
|
|
fa7ff58b-59ac-416b-b045-174ec5c219f3
|
34c7193c-d96f-448e-a617-43d60071f00f
|
labs-f5c83c45-d718-4117-bb7c-9894dba18aef.pdf
|
{"name": "labs-f5c83c45-d718-4117-bb7c {"name": "labs-f5c83c45-d718-4117-bb7c-9894dba18aef.pdf", "content_type": "application/octet-stream", "size": 647630, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-fa7ff58b-59ac-416b-b045-174ec5c219f3"}...
|
1772237228
|
efd61783ea9f2cdfe5caec6179587fcaa2247d81a58bb9eb45 efd61783ea9f2cdfe5caec6179587fcaa2247d81a58bb9eb45aa75960ed162eb...
|
{"status": "completed", "conte {"status": "completed", "content": "Chemistry Specialty Requisition\nCH-0311(Rev2023-04)\nLaboratory Medicine and Pathology\nEdmonton Zone Laboratory Services\nClient Response Centre 780-407-7484\nFasting\n# of hrs\nSpecimen Type\nBlood \u00a3 Serum \u00a3 Plasma\n\u00a3 Whole blood\n\u00a3 m\\Microcollection\nUrine / Feces \u00a3 Random \u00a3 24 hr \n\u00a3 Timed, other ________________\nTotal volume __________________\nStart time/date ________________\nStop time/date ________________\nOther ________________________\nBill Type\n CPL \u00a3 Alberta Health Care OT \u00a3 Out of Prov\nCCO \u00a3 Alberta Health Care Third Party XX \u00a3 Pre-paid\nCO \u00a3 DynaLIFEDX PB \u00a3 Patient Bill\nCo. name ________________________________________________\nAddress _________________________________________________\nClient # __________________________________________________\nSpecimen Event Type\nIA \u00a3 AUXILIARY HC \u00a3 HMCARE\nIP \u00a3 IN PT ST \u00a3 STAFF\nOP \u00a3 OUT PT EN \u00a3 ENVIRON\nAP \u00a3 AMBUL WCB \u00a3 WORKER'S \n COMP\nVITAMIN D\n25VD o 25-Hydroxy Vitamin D\nTesting that does not meet the criteria \nlisted below will NOT be preformed:\n(Check all that are appropriate for your \npatient)\no\nMetabolic bone diseases\no Abnormal blood calcium\no Malabsorption syndromes\n(celiac disease, small intestine surgery,\nanticonvulsant agents)\no Chronic renal disease\no Chronic liver disease\nANTI-NUCLEAR ANTIBODY SCREEN\nANA o Anti-Nuclear Antibody Screen\nANA lacks specificity (high false positive \nrate) as a diagnostic test in the absence \nof relevant clinical symptoms. \nAt least two of the criteria listed below \nshould be identified. \no\nPhotosensitive (\"lupus\") rash\no Arthritis\no Myositis\no Oral ulcers\no Pleurisy or pericarditis\no Glomerulonephritis\no Hemolytic anemia, thrombocytopenia,\nneutropenia or lymphopenia\no Seizures or psychosis\no Raynaud's phenomenon\no Scleroderma skin changes\no Alopecia Areata\no Sicca (dry mouth/dry eyes)\no Suspected Juvenile Arthritis\nBIOCHEMICAL GENETICS\nStrict attention to recommended specimen \ncollection procedures is required. Information \ncan be obtained from \"Guide to Lab Services\" \nor by calling Client Response Centre.\nTPN (last 72 h) o Yes o No\nTransfusion (last 90 days) o Yes o No \nPlasma\nAAQ o Amino Acid Quantitation\nBTDQ o Biotinidase\nBlood\nACBS o Acylcarnitine, Blood Spot\nLCARA o Arylsulfatase A\nLCARB o Arylsulfatase B\nFABRY o Fabry\nGALSC o Galactosemia Screen\nGAUCH o Gaucher\nBGALA o GM1 Gangliosidosis\nPOMPE o Pompe\nKRABBE o Krabbe\nUrine\nUAAQ o Amino Acid Quantitation\nUCYST o Cystinuria Screen\nMPSCS o Mucopolysaccharide Screen\nOLIGO o Oligosaccharide Screen\nORGLC o Organic Acids\nSUGID o Sugar Screen\nUSULF o\tSulfite\tScreen\nStool\nFRED o Reducing Substances\nCSF\nSFAAQ o Amino Acid Quantitation\nTRACE ELEMENTS\nStrict attention to recommended specimen collection procedures \nis required. Information can be obtained from \"Guide to Lab \nServices\" or by calling Client Response Centre.\nPlease complete the following\nEnvironmental exposure to certain trace elements either \noccupationally or in food / medications can cause elevated \ntrace element concentrations. Previous administration \nof GADOLINIUM- or BARIUM-CONTAINING CONTRAST \nMEDIA is known to cause interference with trace elements \ndeterminations.\nOccupational exposure o Yes o No\nDate of exposure ______________ Time of exposure ________\nTrace elements suspected _______________________________\nSerum Whole Blood Urine\nAluminium o ALU o UAL\nAntimony o WBSB o USB\nArsenic o WBAS o UAS\nBarium o SBA o UBA\nBeryllium o SBE o UBER\nBismuth o UBI\nCadmium o BCDM o UCD\nChromium o SCRM o UCRM\nCobalt o WBCO o UCOB\nCopper o SCU o UCU\nLead o WBPB o UPB\nManganese o BMN o UMN\nMercury o WBHG o UHG\nMolybdenum o WBMO\nNickel o NIK o UNIK\nSelenium o SSE o USEL\nThallium o WBTL o UTHAL\nZinc o SZN o UZN\nOTHER TESTS\nScanning Label or Accession # (lab only)\nProvider(s)\n Patient\nCollection\nPHN\nExpiry: ________\nDate of Birth (dd-Mon-yyyy)\nLegal Last Name Legal First Name Middle Name\nAlternate\tIdentifier Preferred Name o Male o Female\no Non-binary o Prefer not to disclose\nPhone\nAddress City/Town Prov Postal Code\nAuthorizing Provider Name (last, first, middle) Copy to Name (last, first, middle) Copy to Name (last, first, middle)\nAddress Phone Address Address\nCC Provider ID CC Submitter ID Legacy ID Phone Phone\nClinic Name Clinic Name Clinic Name\nDate (dd-Mon-yyyy) Time (24 hr) Location Collector ID\n578788878\n1998-12-11\nKash\nDiv\nMequanent\nTed\n52 Castlefall Way NE\nCaglary\nChoose Province\nT3J1M7\n1"}...
|
1772237228
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/fa7ff58b-59ac-416b-b045-174ec5c219f3_labs-f5c83c45-d718-4117-bb7c-9894dba18aef.pdf...
|
null
|
Edit
Delete
|
|
fdd11f64-2b6c-4497-81ce-fb876b0c6738
|
34c7193c-d96f-448e-a617-43d60071f00f
|
letters-2025_10_08_155812_68e6de7428090_2348.pdf
|
{"name": "letters-2025_10_08_155812_68 {"name": "letters-2025_10_08_155812_68e6de7428090_2348.pdf", "content_type": "application/octet-stream", "size": 17645, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-fdd11f64-2b6c-4497-81ce-fb876b0c6738"}...
|
1772237244
|
64a8b7df393b21b83a68cb9fab5e7b55921a8e1d33e98ecf46 64a8b7df393b21b83a68cb9fab5e7b55921a8e1d33e98ecf464041ff3eff06d6...
|
{"status": "completed", "conte {"status": "completed", "content": "201 3151 27st NE\nCalgary, Alberta, T1Y 0B4\nP: (403) 235-4109\nF : F:403.235.4147,\nE: admin@advancedcardiology.ca\nDear Div\nThis is a Message for your appointment on 03 October 2025 07:30 AM with Dr Faisal Hasan for\nEndocrinology Consult.\nKindly arrive 10min before time to fill out paperwork. Keep your schedule open for Two hour.\nKindly call the office on 403-235-4109 if you are unable to make this appointment.\n**DILWALK FAMILY CARE CLINIC ACCEPTING NEW PATIENTS on main floor of Advanced\nCardiology!!**\nRegards\nAdvanced Cardiology Consultants and Diagnostics Inc\n#201 3151 27st NE, Calgary T1Y0B4"}...
|
1772237244
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/fdd11f64-2b6c-4497-81ce-fb876b0c6738_letters-2025_10_08_155812_68e6de7428090_2348.pdf...
|
null
|
Edit
Delete
|
|
feed6959-9744-4625-8669-c18bdecc6452
|
34c7193c-d96f-448e-a617-43d60071f00f
|
dictations-2025_09_12_113156.pdf
|
{"name": "dictations-2025_09_12_113156 {"name": "dictations-2025_09_12_113156.pdf", "content_type": "application/octet-stream", "size": 38804, "data": {"patient_id": "b3e7cc30-1ba8-11f0-b706-c183bb9a9165"}, "collection_name": "file-feed6959-9744-4625-8669-c18bdecc6452"}...
|
1772237375
|
eb552952c652669005a212993813838c7270ec8e646adce6ef eb552952c652669005a212993813838c7270ec8e646adce6ef5902a4ed386fdf...
|
{"status": "completed", "conte {"status": "completed", "content": "201 3151 27st NE\nCalgary, Alberta, T1Y 0B4\nT:4032354109, F:403.235.4147,\nE: admin@advancedcardiology.ca\n\u00a0\nCaddy, Jane\nFax:\u00a0 \u00a0\n\u00a0\nRE:\u00a0Div Kash\nPHN:\u00a0124356789\nDOB:\u00a0\u00a02025-12-12\n\u00a0\u00a0\u00a0\nDear Caddy, Jane,\n\u00a0\u00a0\u00a0\nfcfgbnmkjabsd\n\u00a0\n\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\nYours Sincerely,\n\u00a0\n\u00a0\nDictation\u00a0file:\u00a0Super Admin\u00a0\n\u00a0\nDICTATED\u00a0BUT\u00a0NOT\u00a0READ\u00a0TO\u00a0AVOID\u00a0DELAY\u00a0\n\u00a0\nInformation\u00a0contained\u00a0in\u00a0this\u00a0communication\u00a0may\u00a0be\u00a0confidential\u00a0and\u00a0is\u00a0intended\u00a0only\u00a0for\u00a0the\u00a0use\u00a0of\u00a0the\u00a0recipient(s).\u00a0If\u00a0the\u00a0reader\u00a0of\u00a0this\u00a0message\u00a0is\u00a0not\u00a0the\u00a0intended\u00a0recipient,\u00a0you\u00a0are\u00a0hereby\u00a0notified\u00a0that\u00a0any\u00a0dissemination,\u00a0distribution,\u00a0or\u00a0copying\u00a0of\u00a0this\u00a0communication\u00a0or\u00a0any\u00a0of\u00a0its\u00a0contents\u00a0is\u00a0strictly\u00a0prohibited.\u00a0If\u00a0you\u00a0received\u00a0this\u00a0communication\u00a0in\u00a0error,\u00a0Please\u00a0return\u00a0it\u00a0to\u00a0the\u00a0sender\u00a0and\u00a0contact\u00a0Advanced\u00a0Cardiology\u00a0403-\n235-4109.\ntest\nPage 1 of 1\nName: Div Kash | PHN: 124356789 | DOB: 12 Dec, 2025"}...
|
1772237375
|
/home/sid/xevyo/open-webui-dev/backend/data/upload /home/sid/xevyo/open-webui-dev/backend/data/uploads/feed6959-9744-4625-8669-c18bdecc6452_dictations-2025_09_12_113156.pdf...
|
null
|
Edit
Delete
|